Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Designed to provide broad exposure to the Health Care ETFs category of the market, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a smart beta exchange traded fund launched on 06/19/2006.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
The State Street SPDR S&P Pharmaceuticals ETF (XPH) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market.
XPH: Healthcare Dashboard For January
Healthcare providers have a good value score, and the pharmaceuticals & biotechnology subsector has a good quality score. State Street SPDR S&P Pharmaceuticals ETF provides modified equal-weighted exposure to the pharmaceutical industry, reducing company-specific risk versus cap-weighted peers. XPH is best suited for tactical allocation or swing trading, not as a long-term core holding, given its historical underperformance.
Pharma ETF (XPH) Hits a New 52-Week High
For investors seeking momentum, State Street SPDR S&P Pharmaceuticals ETF XPH is probably on the radar. The fund just hit a 52-week high and rose 61.4% from its 52-week low price of $35.22/share.
US and UK agree zero-tariffs on pharmaceuticals
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products.
US, UK to agree to zero tariffs on pharmaceuticals, announcement expected, sources say
Britain and the United States are poised to agree to zero tariffs on pharmaceutical products, with an announcement due at the White House on Monday, according to two sources familiar with the matter.
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?
Launched on June 19, 2006, the State Street SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
A smart beta exchange traded fund, the State Street SPDR S&P Pharmaceuticals ETF (XPH) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
The SPDR S&P Pharmaceuticals ETF (XPH) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the SPDR S&P Pharmaceuticals ETF (XPH) is a passively managed exchange traded fund launched on 06/19/2006.
